Bullmarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers with a detailed report on the Healthcare IT Industry, including McKesson (NYSE: MCK), Cerner (Nasdaq: CERN), Quality Systems (Nasdaq: QSII), Eclypsis (Nasdaq: ECLP), and HLTH Corp. (Nasdaq: HLTH).
All paid and trial subscribers to BullMarket.com can now receive immediate access to the newsletter’s exclusive daily reports. As a subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today: https://www.bullmarket.com/subscribe/index.php?refer=BMR267B
In its report, BullMarket.com wrote: “On the face of things, the opportunities for companies in this space are almost unlimited. Most doctors still keep massive paper files for each patient stuffed with handwritten notes and test results, sometimes indexed, sometimes not. Then there is the ubiquitous 'chart' at the foot of a patient's hospital bed. Hospital billing systems don't necessarily sync up the systems run by the health insurers and government agencies that actually pay the bulk of those bills. In short, it's an industry ripe for modernization.”
BullMarket.com looked at the following topics, among others:
-- Can Quality Systems continue to be a quality investment for shareholders? What recent IRS ruling could be a boon to the company?
-- Will Cerner's and McKesson's contracts with Britain's National Health Service eventually prove profitable for the two firms?
-- What does Eclypsis' pipeline say about future growth?
-- Which of these stocks has the best prospects going forward?
About BullMarket.com:
Launched in 1997, BullMarket.com has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The BullMarket.com Recommended List includes about 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. BullMarket.com is one of the oldest continuously published investment newsletters online, and its Recommended List has consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts:
Marcie Martin, +1-888-278-5515
